So Now What? Unanswered Questions Regarding Retroperitoneal Sarcomas, Hospital Volume, Multidisciplinary Expertise, and Outcomes
- PMID: 35000078
- DOI: 10.1245/s10434-021-11159-8
So Now What? Unanswered Questions Regarding Retroperitoneal Sarcomas, Hospital Volume, Multidisciplinary Expertise, and Outcomes
Comment on
-
National Trends in Treatment for Retroperitoneal Soft Tissue Sarcoma: A Modern Appraisal of Variability in Therapeutic Strategies.Ann Surg Oncol. 2022 Apr;29(4):2275-2285. doi: 10.1245/s10434-021-10908-z. Epub 2021 Oct 11. Ann Surg Oncol. 2022. PMID: 34635978
References
-
- Villano AM, Vidri RJ, Vo ET, et al. National trends in treatment for retroperitoneal soft tissue sarcoma: a modern appraisal of variability in therapeutic strategies. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10908-z . - DOI - PubMed
-
- Bonvalot S, Gaignard E, Stoeckle E, et al. Survival benefit of the surgical management of retroperitoneal sarcoma in a reference center: a nationwide study of the French Sarcoma Group from the NetSarc database. Ann Surg Oncol. 2019;26:2286–93. - DOI
-
- Keung EZ, Chiang YJ, Cormier JN, et al. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer. 2018;124:4495–503. - DOI
-
- Villano AM, Zeymo A, Chan KS, et al. Identifying the minimum volume threshold for retroperitoneal soft tissue sarcoma resection: merging national data with consensus expert opinion. J Am Coll Surg. 2020;230:151–60. - DOI
-
- Andritsch E, Beishon M, Bielack S, et al. ECCO essential requirements for quality cancer care: soft tissue sarcoma in adults and bone sarcoma: a critical review. Crit Rev Oncol Hematol. 2017;110:94–105. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical